This is part 2 of 2 of the SPACs vs IPOs Panel.

The four panelists who are experienced experts, as it relates to SPACs, answers questions that are give a general idea on what a SPAC is as well as some specifics around the process, advantages, disadvantages, history and what the future of this investment process is going to be. 
 
Adam Spector – Partner at DLA Piper
Tracy Harrison – Partner at Deloitte
Shaan Kapoor – Partner at Green Kap Advisors
Chris Jeffery – Partner at Baker Tilly 

·        What the heck is a SPAC and how does it work?

·        What does the SPAC market look like today?

·        From an accounting and auditing point of view, what are the biggest differences between a traditional IPO and going public via a SPAC?
 
·        How much time does a company need to prepare for an IPO? 
 
·        What are some of the key work steams both pre and post SPAC transactions?
·        What are some of the leading practices as it relates to preparing for the post SPAC transaction?
 
·        What are some of the biggest financial reporting risks to consider and hurdles to overcome when going public, especially via a SPAC
 
·        How have SPACs performed in the long run vs companies that have gone the IPO route?

1.   SPACs have been very popular in the Cannabis industry over the last 12-18 months.  Why is that the case and do you see this trend continuing?  How have Cannabis SPACs performed?
 
·        What does the De-SPAC process look like?

·        What are the benefits of a SPAC merger?
 
·        Why do investors provide equity and capital to SPACs and their promoters without knowing what the actual investment and transaction will be?

свернуть